Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study (Q40877051)

24 September 2017

Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study (English)

1 reference

24 September 2017

0 references

1 reference

1 reference

Michael W Tanck

6

0 references

Diederik van de Beek

object named as

Diederik van de Beek

series ordinal

8

0 references

Arie van der Ende

series ordinal

7

object named as

Arie van der Ende

1 reference

24 September 2017

2

Matthijs C Brouwer

1 reference

PubMed ID

26652862

E Soemirien Kasanmoentalib

24 September 2017

series ordinal

3

object named as

E Soemirien Kasanmoentalib

1 reference

24 September 2017

4

Anne T Kloek

1 reference

24 September 2017

1

Merijn W Bijlsma

1 reference

24 September 2017

5

Marjolein J Lucas

1 reference

24 September 2017

30 November 2015

1 reference

Lancet Infectious Diseases

24 September 2017

1 reference

24 September 2017

16

1 reference

24 September 2017

3

1 reference

24 September 2017

339-347

1 reference

Clinical features and prognostic factors in adults with bacterial meningitis

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Effect of vaccines on bacterial meningitis worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Advances in treatment of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Bacterial meningitis in the United States, 1998-2007.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Dexamethasone in adults with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Dexamethasone in adults with community-acquired bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Progress and challenges in bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Hearing loss in adults surviving pneumococcal meningitis is associated with otitis and pneumococcal serotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Delayed cerebral thrombosis in bacterial meningitis: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Outcome in patients with bacterial meningitis presenting with a minimal Glasgow Coma Scale score

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Endocarditis in adults with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Bacterial meningitis in adults after splenectomy and hyposplenic states

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Plasminogen activator inhibitor-1 influences cerebrovascular complications and death in pneumococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Streptococcus pneumoniae arginine synthesis genes promote growth and virulence in pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Adjunctive dexamethasone in adults with meningococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

The incidence of bacterial meningitis in the Netherlands--a comparison of three registration systems, 1977-1982

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Nosocomial bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Non-neonatal meningitis due to less common bacterial pathogens, the Netherlands, 1975-83.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

A study of 280 cases of neonatal meningitis in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Steroids in adults with acute bacterial meningitis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Acute bacterial meningitis in adults. A review of 493 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Community-Acquired Recurrent Bacterial Meningitis in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Community-acquired bacterial meningitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900430-2

7 January 2021

10.1016/S1473-3099(15)00430-2

Identifiers

DOI

1 reference

release_rsks6h3vfjgcdetajvnoxjkqq4

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rsks6h3vfjgcdetajvnoxjkqq4

24 November 2022

mapped directly with Wikidata item

PubMed ID

26652862

1 reference

PubMed ID

26652862